158 related articles for article (PubMed ID: 9184704)
1. Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
Gardner SF; Marx MA; White LM; Granberry MC; Skelton DR; Fonseca VA
Ann Pharmacother; 1997 Jun; 31(6):677-82. PubMed ID: 9184704
[TBL] [Abstract][Full Text] [Related]
2. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin in diabetes-associated hypercholesterolemia.
Rustemeijer C; Schouten JA; Janssens EN; Spooren PF; van Doormaal JJ
Acta Diabetol; 1997 Dec; 34(4):294-300. PubMed ID: 9451475
[TBL] [Abstract][Full Text] [Related]
5. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
6. Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose.
Davidson MH; Rooney M; Pollock E; Drucker J; Choy Y
J Clin Lipidol; 2013; 7(5):423-32. PubMed ID: 24079283
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
Harada N; Kashiwagi A; Nishio Y; Kikkawa R
Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
12. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
Nishimura R; Sone H; Nakagami T; Tajima N
Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.
Krempf M; Berthezène F; Wemeau JL; Moinade S; Desriac I; Amelineau E; Passa P
Diabetes Metab; 1997 Apr; 23(2):131-6. PubMed ID: 9137901
[TBL] [Abstract][Full Text] [Related]
15. Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients.
Soonthornpun S; Rattarasarn C; Leelawattana R; Thamprasit A
J Med Assoc Thai; 1997 Jan; 80(1):9-15. PubMed ID: 9078811
[TBL] [Abstract][Full Text] [Related]
16. Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.
Kietsiriroje N; Leelawattana R
BMC Res Notes; 2015 Jul; 8():294. PubMed ID: 26148680
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group.
Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M
Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.
Davignon J; Roederer G; Montigny M; Hayden MR; Tan MH; Connelly PW; Hegele R; McPherson R; Lupien PJ; Gagné C
Am J Cardiol; 1994 Feb; 73(5):339-45. PubMed ID: 8109547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
